The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
US8623901, 256 ID: ALA3693849
PubChem CID: 135912147
Max Phase: Preclinical
Molecular Formula: C20H19ClN6O2
Molecular Weight: 410.87
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=c1[nH]c(Cc2cc(Cl)ccc2-n2cccn2)nc2c1cnn2C1CCOCC1
Standard InChI: InChI=1S/C20H19ClN6O2/c21-14-2-3-17(26-7-1-6-22-26)13(10-14)11-18-24-19-16(20(28)25-18)12-23-27(19)15-4-8-29-9-5-15/h1-3,6-7,10,12,15H,4-5,8-9,11H2,(H,24,25,28)
Standard InChI Key: JVCRASCWWMFLBH-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 33 0 0 0 0 0 0 0 0999 V2000
0.2470 -5.8459 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1.2883 -5.2495 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5847 -6.0040 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8864 -5.2585 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8915 -3.7585 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5951 -3.0039 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5973 -1.5031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4133 1.7530 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8032 3.1233 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.3115 2.9665 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.6928 4.0817 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3384 5.5341 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4233 6.5700 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8628 6.1485 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.2175 4.6910 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1327 3.6551 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3383 -1.3500 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.2935 -3.7495 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1938 -3.0126 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.3392 -1.5325 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8080 -1.2280 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5514 -2.5308 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5421 -3.6405 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 2 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 10 1 0
14 15 1 0
15 16 1 0
16 17 1 0
17 18 1 0
18 19 1 0
19 20 1 0
20 15 1 0
11 21 1 0
21 22 2 0
21 23 1 0
23 8 1 0
6 24 2 0
24 2 1 0
5 25 1 0
25 26 1 0
26 27 2 0
27 28 1 0
28 29 2 0
29 25 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 410.87Molecular Weight (Monoisotopic): 410.1258AlogP: 2.90#Rotatable Bonds: 4Polar Surface Area: 90.62Molecular Species: NEUTRALHBA: 7HBD: 1#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 9.16CX Basic pKa: 1.61CX LogP: 1.78CX LogD: 1.77Aromatic Rings: 4Heavy Atoms: 29QED Weighted: 0.56Np Likeness Score: -2.15
References 1. (2014) Compounds for the treatment of CNS disorders,